The Influence of Timing of Cabergoline Initiation on Prevention of Ovarian Hyper Stimulation Syndrome in Patients Undergoing Intra Cytoplasmic Sperm Injection .
Phase of Trial: Phase III
Latest Information Update: 01 Mar 2017
At a glance
- Drugs Cabergoline (Primary)
- Indications Ovarian hyperstimulation syndrome
- Focus Therapeutic Use
- 21 Feb 2017 Planned End Date changed from 1 Jul 2016 to 1 Jun 2017.
- 21 Feb 2017 Planned primary completion date changed from 1 May 2016 to 1 Jun 2017.
- 08 Dec 2015 New trial record